Top Trends Transforming the Cardiovascular Surgery Devices And Equipment Market Landscape in 2025: GE HealthCare Launches CardioVisio for AFib to Enhance Precision Care and Streamline Clinical Workflows

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Cardiovascular Surgery Devices And Equipment Industry Market Size Be by 2025?
The size of the market for cardiovascular surgery devices and equipment has seen robust expansion in the last few years. The market is projected to inflate from $1.89 billion in 2024 to $1.99 billion in 2025, experiencing a compound annual growth rate (CAGR) of 5.3%. This augmentation in the historic phase can be accredited to factors such as the prevalence of cardiovascular conditions, advancements in technology, the variances in population age, and the management of persistent diseases.

What's the Long-Term Growth Forecast for the Cardiovascular Surgery Devices And Equipment Market Size Through 2029?
The market size for cardiovascular surgery devices and equipment is projected to experience a slight upturn in the forthcoming years. The market is set to escalate to $2.15 billion in 2029 with a compound annual growth rate (CAGR) of 1.9%. Factors contributing to this growth in the prediction period include advancements in minimally invasive surgery, sophisticated imaging, personalized medicine, along with telemedicine and teleconsultations. Other notable trends during the forecast period encompass hybrid operating rooms, transcatheter procedures, the incorporation of artificial intelligence (AI) in surgical procedures, and distance surgical training.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

What Are the Key Growth Drivers Fueling the Cardiovascular Surgery Devices And Equipment Market Expansion?
The growing number of elderly individuals, coupled with a rise in mortality rates from cardiovascular diseases, is propelling the market for cardiovascular surgical devices. Data from the American Heart Association (AHA) indicates that around 43.7 million people over 60 years of age in the US are afflicted with cardiovascular diseases. The AHA also estimates that globally, annual deaths resulting from heart diseases amount to 17.3 million, and this figure is projected to exceed 23.6 million by 2030. The increase in surgeries resulting from these factors is fueling the growth of the market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp

What Are the Key Trends Driving Cardiovascular Surgery Devices And Equipment Market Growth?
Leading organizations are pumping resources into enterprises active in the Cardiovascular Surgery Devices and Equipment market, focusing on the evolution of inventive solutions like CardioVisio for Atrial Fibrillation (AFib). These innovative solutions aim at enhancing early detection, bettering patient results, and smoothing the process of treatment. CardioVisio for Atrial Fibrillation (AFib) is a sophisticated diagnostic and supervisory solution purposed to identify and manage AFib, a prevalent abnormal heart rhythm. To illustrate, in August 2023, GE HealthCare, a medical technology firm based in the US, rolled out CardioVisio for Atrial Fibrillation (AFib), a digitally driven clinical decision-making tool aimed at improving precise care for AFib patients. Launched at the ESC Congress 2023, this inventive solution amalgamates longitudinal patient records from diverse sources, supplying clinicians with a thorough understanding of heart wellness. With its evidence-driven suggestions that align with AFib protocols, CardioVisio enhances clinical workflows and reinforces adherence to best practice guidelines.

How Is the Cardiovascular Surgery Devices And Equipment Market Segmented?
The cardiovascular surgery devices and equipment market covered in this report is segmented -

1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables
2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications
3) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research Laboratories

Subsegments:
1) By Beating Heart Surgery Systems: Stabilization Systems, Tissue Stabilizers, Coronary Artery Bypass Surgery Systems, Other Beating Heart Surgery Devices
2) By Cardiopulmonary Bypass Equipment: Heart-Lung Machines, Oxygenators, Cannulas, Tubing Packs, Cardioplegia Delivery Systems, Other Cardiopulmonary Bypass Equipment
3) By Cardiac Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices, Laser Ablation Devices, Microwave Ablation Devices, Other Cardiac Ablation Devices
4) By Perfusion Disposables: Blood Oxygenators, Perfusion Cannulas, Tubing Sets, Filters, Blood Reservoirs, Other Perfusion Disposables

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2389&type=smp

Which Companies Are Leading the Charge in Cardiovascular Surgery Devices And Equipment Market Innovation?
Major companies operating in the cardiovascular surgery devices and equipment market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., Angiodynamics, Transmedics, Terumo cardiovascular systems corporation, Edwards Life Science Corporation, Medtronic plc, Cardinal Health, Cyberheart Incorporated, Medwaves Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.P.A., Biosensors International, Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., Krdium Inc., SEMMT Inc., Amaranth Medical, 3M Health Care, Abaxis Inc., Atlas Genetics, Becton Dickinson and Company, BioFire Diagnostics, bioMérieux, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, EKF Diagnostics, GenMark Diagnostics, Hologic, LumiraDx, Mesa Biotech (a subsidiary of Thermo Fisher Scientific), Nova Biomedical, NOWDiagnostics, Opko Health, OraSure Technologies, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Trividia Health, Trivitron Healthcare, Werfen S.A.

Which Regions Are Leading the Global Cardiovascular Surgery Devices And Equipment Market in Revenue?
North America was the largest region in the global cardiovascular surgery devices and equipment market in 2023. Western Europe was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2389

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.